Abstract:OBJECTIVES: Under current economic and financial framework, some important revisions were made to the National Pharmaceutical Policy in Portugal, aimed at decreasing prices and contributing to lower public expenditure in the Health Sector. The Decree-Law 112/2011 introduced a new margin system both for pharmacies and wholesalers. A linear margin scheme, expressed as a percentage mark-up on the consumer price before VAT was thus replaced by a regressive system combining: i) a fixed fee that increases with the e… Show more
“…3 [ 18 ], the rate at which new RSAs were being implemented levelled out. Although the number of drugs with RSAs attached to them plateaued in 2012–2013, the majority of the new schemes were financial based, demonstrating a shift away from PBRSAs to minimize administrative burden [ 16 – 18 ]. Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Over the last 15 years, several articles have reported an increase in [ 12 , 16 – 21 ] or discussed the implications of RSAs [ 7 , 22 ]. However, to the best of our knowledge, no article has evaluated the number of articles about RSAs alongside the implications of their use to discuss the overall trends in RSA development.…”
ObjectiveOur objectives were to explore the changes in the level of interest in risk-sharing agreements (RSAs) in the EU during the last 15 years and the underlying reasons for these changes.MethodsA systematic literature review was conducted using PubMed, Scopus, Web of Science, and Embase. Articles identified were divided into ‘quantitative articles’ used to establish the level of interest and ‘qualitative articles’ used to identify the underlying trends in RSAs.ResultsThe literature search retrieved 2144 scientific articles. Data were extracted from 238 articles. Of these, 100 contained quantitative data and 138 contained qualitative data. The pace of articles being published about RSAs grew significantly in 2015, which related to the increase in interest in and knowledge about RSAs. The underlying reasons for the fluctuations were condensed into four overall themes: (1) push for value-based pricing, (2) economic crisis and further push to contain costs, (3) criticism of RSAs in the real world, and (4) diversification of RSAs to fit the purpose.ConclusionThe overall level of interest in RSAs in the EU has been increasing since 2000; therefore, articles reporting the number of RSAs implemented and case studies have been steadily growing as evidence is becoming more readily available. The number of qualitative articles reporting and discussing the underlying reasons for these changes in interest has largely fluctuated over the last 15 years. Despite these fluctuations, interest in RSAs remains high.Electronic supplementary materialThe online version of this article (doi:10.1007/s41669-017-0044-1) contains supplementary material, which is available to authorized users.
“…3 [ 18 ], the rate at which new RSAs were being implemented levelled out. Although the number of drugs with RSAs attached to them plateaued in 2012–2013, the majority of the new schemes were financial based, demonstrating a shift away from PBRSAs to minimize administrative burden [ 16 – 18 ]. Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Over the last 15 years, several articles have reported an increase in [ 12 , 16 – 21 ] or discussed the implications of RSAs [ 7 , 22 ]. However, to the best of our knowledge, no article has evaluated the number of articles about RSAs alongside the implications of their use to discuss the overall trends in RSA development.…”
ObjectiveOur objectives were to explore the changes in the level of interest in risk-sharing agreements (RSAs) in the EU during the last 15 years and the underlying reasons for these changes.MethodsA systematic literature review was conducted using PubMed, Scopus, Web of Science, and Embase. Articles identified were divided into ‘quantitative articles’ used to establish the level of interest and ‘qualitative articles’ used to identify the underlying trends in RSAs.ResultsThe literature search retrieved 2144 scientific articles. Data were extracted from 238 articles. Of these, 100 contained quantitative data and 138 contained qualitative data. The pace of articles being published about RSAs grew significantly in 2015, which related to the increase in interest in and knowledge about RSAs. The underlying reasons for the fluctuations were condensed into four overall themes: (1) push for value-based pricing, (2) economic crisis and further push to contain costs, (3) criticism of RSAs in the real world, and (4) diversification of RSAs to fit the purpose.ConclusionThe overall level of interest in RSAs in the EU has been increasing since 2000; therefore, articles reporting the number of RSAs implemented and case studies have been steadily growing as evidence is becoming more readily available. The number of qualitative articles reporting and discussing the underlying reasons for these changes in interest has largely fluctuated over the last 15 years. Despite these fluctuations, interest in RSAs remains high.Electronic supplementary materialThe online version of this article (doi:10.1007/s41669-017-0044-1) contains supplementary material, which is available to authorized users.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
